|
|
|
Volumn 28, Issue 2, 1996, Pages 995-997
|
|
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: The Memphis experience
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CREATININE;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
OKT 3;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CREATININE CLEARANCE;
DRUG MEGADOSE;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEADACHE;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
MALE;
NEPHROTOXICITY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RECIPIENT;
TREMOR;
ADOLESCENT;
ADULT;
AMYLASES;
ANTILYMPHOCYTE SERUM;
AZATHIOPRINE;
CREATININE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MUROMONAB-CD3;
PANCREAS TRANSPLANTATION;
RECURRENCE;
STEROIDS;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0029913176
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (0)
|
